Enriching the lives of pets and their owners through breakthrough therapeutics

At TriviumVet we develop innovative companion animal veterinary therapeutics.

Strategic focus on the development and commercialisation of novel therapeutics and diagnostics for companion animals.

Highly experienced team with extensive expertise in animal health and a track record of developing and commercialising, pharmaceutical products and supported by world class Key Opinion Leaders.

Portfolio of Intellectual Property across our product range.

Our One Health approach to developing treatments that target diseases in companion animals means our research can translate into the human field.

Our research and development model is simple but effective.

WE IDENTIFY

We identify diseases in companion animals where there are no approved treatments.

WE FORMULATE

We formulate novel solutions with species specific doses and presentations.

WE TRIAL

Our translational research team are bridging the gap between bench and bedside by conducting clinical trials that benefit client-owned dogs and cats.

WE COLLATE

The data collected is then used both as clinical data for veterinary patients and preclinical data for human patients.

WE PROVE

We prove the safety and efficacy of our products to FDA and EMA requirements.

WE TRANSLATE

We harness our extensive animal research to identify synergies in human medicine.

Our research and development model is simple but effective.

WE IDENTIFY

We identify diseases in companion animals where there are no approved treatments.

WE FORMULATE

We formulate novel solutions with species specific doses and presentations.

WE TRIAL

Our translational research team are bridging the gap between bench and bedside by conducting clinical trials that benefit client-owned dogs and cats.

WE COLLATE

The data collected is then used both as clinical data for veterinary patients and preclinical data for human patients.

WE PROVE

We prove the safety and efficacy of our products to FDA and EMA requirements.

WE TRANSLATE

We harness our extensive animal research to identify synergies in human medicine.

Insights

Keep up to date with our latest advancements and news as we continue to develop and commercialise medicines and diagnostics for use in companion animals.

TriviumVet work with The Ohio State University evaluating the benefit of Rapamycin in cats.

We are delighted to be working with The Ohio State University on an exciting clinical trial

April 15, 2022
TriviumVet support UC Davis and the Morris Animal Foundation in a novel research.

We are excited to support UC Davis and the Morris Animal Foundation in a novel research. Subvalvular aortic stenosis (SAS)

April 11, 2022
A great catch up with our colleagues in the US.

Our CTO Stuart Fitzgerald and Regulatory Affairs Manager Susan Kennedy had a successful trip to the US

March 11, 2022

“Until one has loved an animal, a part of one’s soul remains unawakened”

Anatole France